Tuberculin and anergy skin testing of patients receiving long-term hemodialysis
- PMID: 9440563
- DOI: 10.1378/chest.113.1.25
Tuberculin and anergy skin testing of patients receiving long-term hemodialysis
Abstract
Study objectives: Immunocompromised patients with chronic renal failure requiring hemodialysis (HD) are at increased risk of developing tuberculosis (TB). Routine TB screening of this population is recommended. This study examined the frequency of TB reactions and anergy in HD patients in a community with a high prevalence of TB.
Design: Outpatients in a hospital-based HD center were screened with tuberculin, Candida, and mumps antigen.
Results: Forty percent of patients were anergic and 19% were tuberculin reactors. No demographic factors correlated with either test results.
Conclusions: There was a high rate of TB infection and anergy in this HD center. Despite the high rate of anergy, tuberculin testing remains a useful test in this population. Anergic patients require further clinical evaluation for TB. Other HD programs should tuberculin and anergy test their patients to determine prevalence in their populations.
Comment in
-
Tuberculin responsiveness in hemodialysis patients.Chest. 1998 Sep;114(3):947-8. doi: 10.1378/chest.114.3.947-b. Chest. 1998. PMID: 9743198 No abstract available.
Similar articles
-
Tuberculosis infection and anergy in hemodialysis patients.Am J Kidney Dis. 1998 May;31(5):848-52. doi: 10.1016/s0272-6386(98)70055-1. Am J Kidney Dis. 1998. PMID: 9590196
-
Tuberculin skin test results and the booster phenomenon in two-step tuberculin skin testing in hemodialysis patients.Ren Fail. 2005;27(4):425-8. Ren Fail. 2005. PMID: 16060131
-
The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: tuberculin test and the risk of post-transplant tuberculosis.Nephrol Dial Transplant. 2005 Dec;20(12):2720-4. doi: 10.1093/ndt/gfi141. Epub 2005 Sep 27. Nephrol Dial Transplant. 2005. PMID: 16188895
-
The negative tuberculin test. Tuberculin, HIV, and anergy panels.Am J Respir Crit Care Med. 1994 Jun;149(6):1699-709. doi: 10.1164/ajrccm.149.6.7710481. Am J Respir Crit Care Med. 1994. PMID: 7710481 Review. No abstract available.
-
Diagnosis of tuberculosis in dialysis patients: current strategy.Clin J Am Soc Nephrol. 2010 Jun;5(6):1114-22. doi: 10.2215/CJN.09231209. Epub 2010 Apr 22. Clin J Am Soc Nephrol. 2010. PMID: 20413440 Review.
Cited by
-
Incidental lymphadenopathy in renal transplantation.Ann R Coll Surg Engl. 2024 Mar;106(3):245-248. doi: 10.1308/rcsann.2023.0043. Epub 2023 Jul 25. Ann R Coll Surg Engl. 2024. PMID: 37489513 Free PMC article.
-
Interferon-gamma release assays for diagnosis of latent TB infection in chronic kidney diseases and dialysis patients.Front Cell Infect Microbiol. 2022 Nov 14;12:1046373. doi: 10.3389/fcimb.2022.1046373. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36452296 Free PMC article.
-
The Dynamic Change of Immune Checkpoints and CD14+ Monocytes in Latent Tuberculosis Infection.Biomedicines. 2021 Oct 15;9(10):1479. doi: 10.3390/biomedicines9101479. Biomedicines. 2021. PMID: 34680598 Free PMC article.
-
Value of gamma interferon enzyme-linked immunospot assay in the diagnosis of peritoneal dialysis-associated tuberculous peritonitis.Int Urol Nephrol. 2022 Apr;54(4):843-849. doi: 10.1007/s11255-021-02960-1. Epub 2021 Jul 14. Int Urol Nephrol. 2022. PMID: 34263436 Free PMC article.
-
Completion and Adverse Drug Events of Latent Tuberculosis Infection Treatment in Patients Receiving Dialysis: Predictors and Impacts of Different Regimens in a Prospective Cohort Study.Antimicrob Agents Chemother. 2021 Feb 17;65(3):e02184-20. doi: 10.1128/AAC.02184-20. Print 2021 Feb 17. Antimicrob Agents Chemother. 2021. PMID: 33361292 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
